[go: up one dir, main page]

PL3137057T3 - Kompozycje ciekłe metforminy o przedłużonym uwalnianiu - Google Patents

Kompozycje ciekłe metforminy o przedłużonym uwalnianiu

Info

Publication number
PL3137057T3
PL3137057T3 PL15786475T PL15786475T PL3137057T3 PL 3137057 T3 PL3137057 T3 PL 3137057T3 PL 15786475 T PL15786475 T PL 15786475T PL 15786475 T PL15786475 T PL 15786475T PL 3137057 T3 PL3137057 T3 PL 3137057T3
Authority
PL
Poland
Prior art keywords
metformin
extended release
liquid compositions
release liquid
compositions
Prior art date
Application number
PL15786475T
Other languages
English (en)
Inventor
Ashish Kumar
Rajesh Srikrishan Shear
Satishkumar Jain
Romi Barat Singh
Paras P. JAIN
Original Assignee
Sun Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Industries Ltd filed Critical Sun Pharmaceutical Industries Ltd
Publication of PL3137057T3 publication Critical patent/PL3137057T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL15786475T 2014-05-01 2015-05-01 Kompozycje ciekłe metforminy o przedłużonym uwalnianiu PL3137057T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1182DE2014 2014-05-01
PCT/IB2015/053207 WO2015166472A1 (en) 2014-05-01 2015-05-01 Extended release liquid compositions of metformin
EP15786475.2A EP3137057B1 (en) 2014-05-01 2015-05-01 Extended release liquid compositions of metformin

Publications (1)

Publication Number Publication Date
PL3137057T3 true PL3137057T3 (pl) 2021-04-06

Family

ID=54358255

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15786475T PL3137057T3 (pl) 2014-05-01 2015-05-01 Kompozycje ciekłe metforminy o przedłużonym uwalnianiu

Country Status (10)

Country Link
US (1) US20160228360A1 (pl)
EP (1) EP3137057B1 (pl)
AU (1) AU2015254874A1 (pl)
CA (1) CA2947515A1 (pl)
MA (1) MA42000A (pl)
MX (1) MX2016014321A (pl)
PL (1) PL3137057T3 (pl)
RU (1) RU2016147008A (pl)
WO (1) WO2015166472A1 (pl)
ZA (1) ZA201607714B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10258583B2 (en) 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
CA2956902A1 (en) 2014-07-30 2016-02-04 Sun Pharmaceutical Industries Limited Dual-chamber pack
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions
KR20200021774A (ko) * 2018-08-21 2020-03-02 대화제약 주식회사 시타글립틴 속방층을 포함하는 제제의 제조방법, 상기 제조방법으로 제조된 제제, 시타글립틴 속방층 코팅 방법, 및 시타글립틴 속방층 코팅용 조성물
WO2023084320A1 (en) * 2021-11-11 2023-05-19 V-Ensure Pharma Technologies Private Limited Reconstitutable, single use antidiabetic compositions
CN115227660B (zh) * 2022-09-21 2022-12-16 北京惠之衡生物科技有限公司 一种盐酸二甲双胍缓释片及其制备方法
WO2025120540A1 (en) * 2023-12-05 2025-06-12 Sun Pharmaceutical Industries Limited Method of reducing nitrosamine levels in pharmaceutical products and improved formulations thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273760A (en) * 1991-12-24 1993-12-28 Euroceltigue, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
DE4432757A1 (de) * 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
IL143846A0 (en) * 1998-12-23 2002-04-21 Alza Corp Dosage forms comprising porous particles
WO2003084518A2 (fr) * 2002-04-09 2003-10-16 Flamel Technologies Suspension orale de microcapsules de principes actifs
US7214387B2 (en) * 2002-08-02 2007-05-08 Penwest Pharmaceuticals Company Sustained release formulations of metformin
WO2006086856A1 (en) * 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
CN101160126A (zh) * 2005-04-20 2008-04-09 默克公司 血管紧张肽ⅱ受体拮抗剂
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
CA2719342C (en) * 2008-02-29 2016-04-26 Pgt Photonics S.P.A Optical mode transformer, in particular for coupling an optical fiber and a high-index contrast waveguide
WO2010011466A2 (en) * 2008-06-27 2010-01-28 Otonomy, Inc. Controlled-release cns modulating compositions and methods for the treatment of otic disorders
WO2010045656A2 (en) * 2008-10-17 2010-04-22 Nectid, Inc. Novel sglt2 inhibitor dosage forms
EP2385823A4 (en) * 2009-01-09 2014-02-12 Panacea Biotec Ltd PHARMACEUTICAL SUSPENSION WITH DOUBLE RELEASE
WO2011107855A2 (en) * 2010-03-04 2011-09-09 Torrent Pharmaceuticals Limited Sustained release oral liquid suspension dosage form
EP2392319A1 (en) * 2010-06-04 2011-12-07 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical compositions of co-crystals of tramadol and coxibs

Also Published As

Publication number Publication date
ZA201607714B (en) 2017-11-29
AU2015254874A1 (en) 2016-11-17
WO2015166472A9 (en) 2016-06-16
RU2016147008A (ru) 2018-06-04
EP3137057B1 (en) 2020-09-09
US20160228360A1 (en) 2016-08-11
MA42000A (fr) 2018-03-07
WO2015166472A1 (en) 2015-11-05
EP3137057A4 (en) 2017-12-13
EP3137057A1 (en) 2017-03-08
MX2016014321A (es) 2017-05-23
CA2947515A1 (en) 2015-11-05

Similar Documents

Publication Publication Date Title
IL280485A (en) Sustained-release pridopidine preparations
ZA201705060B (en) Use of picolinamides as fungicides
PL3387904T3 (pl) Ciekłe kompozycje chwastobójcze zawierające sulfonylomocznik
IL249134A0 (en) Preparation of polycyclic carbamoylpyridone compounds
SMT202100441T1 (it) Composizioni di composti e loro usi
PL3099381T3 (pl) Kompozycje środków zapachowych o przedłużonym uwalnianiu
ZA201607714B (en) Extended release liquid compositions of metformin
SI3154526T1 (sl) Trdne oblike sofosbuvira
IL246979A0 (en) Crystalline forms of sofosbuvir
GB201406542D0 (en) Intumescent compositions
EP3288539A4 (en) EXTENDED RELEASE LIQUID METFORMIN COMPOSITIONS
ZA201700518B (en) Use of active compound compositions
GB201407822D0 (en) Use of a composition
HRP20211354T8 (hr) Tekuće kompozicije tiourilena
IL249130A0 (en) Preparation of piperidine-4-carbthioamide
GB2530071B (en) Antifouling composition
GB201408233D0 (en) Use of polyanionic composition
GB201418410D0 (en) use of compositions of matter
IL249332A0 (en) Crystalline forms of sofosbuvir
GB201412359D0 (en) Composition of objects
GB201412089D0 (en) Composition of objects
GB201418773D0 (en) Mechanism of action
GB201415634D0 (en) Novel compositions
GB201406863D0 (en) Compositions comprising variegin